nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—female reproductive system—fallopian tube cancer	0.243	0.243	CbGeAlD
Lorazepam—TSPO—epithelium—fallopian tube cancer	0.117	0.117	CbGeAlD
Lorazepam—TSPO—uterine cervix—fallopian tube cancer	0.116	0.116	CbGeAlD
Lorazepam—TSPO—endometrium—fallopian tube cancer	0.105	0.105	CbGeAlD
Lorazepam—TSPO—uterus—fallopian tube cancer	0.0966	0.0966	CbGeAlD
Lorazepam—TSPO—female reproductive system—fallopian tube cancer	0.0869	0.0869	CbGeAlD
Lorazepam—TSPO—female gonad—fallopian tube cancer	0.079	0.079	CbGeAlD
Lorazepam—GABRB3—female reproductive system—fallopian tube cancer	0.0789	0.0789	CbGeAlD
Lorazepam—TSPO—vagina—fallopian tube cancer	0.0786	0.0786	CbGeAlD
